Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Given the growing demand for effective weight loss solutions among people with obesity, this timeline could be accelerated if the drug continues to show positive outcomes
For a deeper discussion of the study design and findings, see our full GLP-1 receptor agonist feasibility study on linear vs fragment SPPS
J&J scoops up startup to enter KRAS race Johnson & Johnson said yesterday it will spend $1 billion to acquire Firefly Bio, a startup focused on the buzzy field of KRAS inhibitors
Faster Progression Reach formulation decisions sooner and move forward with more confidence
Aim for 56 smaller meals or snacks daily
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
